DOCTOR RAWLINGS

Trusted Medical Portal For Daily Health Tips

Medical Portal For Daily Health and Lifestyle Tips

Monkeypox Outbreak: US Cases Skyrocketing

Share on facebook
Share on twitter
Share on whatsapp
Share on pinterest
Share on linkedin
Share on print
Monkeypox Outbreak

By Rawlings Oke Godwin

On 12 Aug, 2022

Share on facebook
Share on twitter
Share on whatsapp
Share on telegram
Share on pinterest
Share on linkedin

Monkeypox Outbreak: US Record Over 10,000 Cases

Despite the fact that more than 10,000 Americans have tested positive in the ongoing monkeypox outbreak across the country, according to statistics released late Wednesday by the Centers for Disease Control and Prevention, federal health officials say they are still rushing to contain the virus.

Every state except Wyoming has recorded cases, and 15 states plus DC have reported over a hundred cases. New York, California, and Florida have the most.

Monkeypox Outbreak & Death

Even though 12 people have lost their lives to monkeypox this year, none of them were from the United States, according to the most recent WHO statistics.

Epidemiologists say that the virus is most often spread when men have close contact with other men, such as when they touch each other’s skin or share personal items like towels and blankets.

The Centers for Disease Control and Prevention (CDC) has, however, recorded at least 50 cases in females who were born to infected individuals, including at least one pregnant woman. A small number of cases in children have also been reported. However, subsequent reports from health officials suggest that some of these cases may have been false positives.

Health officials in the U.S. have been warning for weeks that the outbreak is likely to get worse in August as more people get access to diagnostic testing. This is similar to what happened in other European countries earlier in the year, where the number of cases went up.

Since late July, the United States has reported more cases than any other country. At the moment, there are about twice as many cases in the United States as there are in Spain, which had the most cases in Europe before Germany and the United Kingdom.

Monkeypox Outbreak And CDC

It appears that fresh cases in certain other nations are beginning to taper down. Although the CDC’s total is lower than in other European countries when adjusted for population size, the increasing U.S. outbreak is now certain to surpass those rates as well.

The CDC has recently projected that the rate of new cases of monkeypox in states with more than 25 cases doubles every 8.6 days on average.

The Centers for Disease Control and Prevention received reports of 1,391 new cases across the country on Wednesday, the highest daily total. The current U.S. outbreak had its first recorded case around the middle of May.

On Tuesday, Jennifer McQuiston, the CDC’s top monkeypox official, told a group of the agency’s outside advisers that the organization was still operating under a containment goal, but that many states were beginning to wonder if it was time to shift to more of a mitigation phase given the rapid increase in reported cases.

Last week, the Food and Drug Administration approved emergency use of a way to use smaller doses of the Jynneos monkeypox vaccine. This could effectively quadruple the number of shots available in the U.S., which could make this job easier in the coming weeks.

Authorities think that by giving the vaccine between the layers of skin instead of deeper into the arm, it might be possible to vaccinate up to five times as many people with each vial.

Even though the CDC has always told people who have been vaccinated to keep taking “steps to protect themselves from infection” during the outbreak, they have also warned that there isn’t a lot of information about how well the Jynneos vaccine works to stop monkeypox and stop it from spreading.

Immunization

A small number of cases of breakthrough infections after receiving at least one dose of the Jynneos vaccine have been previously documented by the agency. Early data from France, where the vaccine is sold under the brand name Imvanex, also showed that there were new infections.

The new “intradermal” technique for immunizations, which uses different needles and processes than the standard “subcutaneous” shot, will take some time to scale up, local health experts warn.

“No, we won’t merely say, “Let’s get going.” We will make sure that all of the necessary documents, such as provider agreements and training requirements, are up-to-date. To give you an idea of the timeline involved, our first conversation with the CDC is scheduled for this coming Friday. To put it differently than “here’s the EUA, go,” Dr. Allison Arwady is the city of Chicago’s top doctor.

Arwady, vice chair of the Big Cities Health Coalition, said that it could take up to three weeks for health departments all over the country to start using the new dose-sparing method.

No Bulk Vaccination Recommended Yet

As of right now, the CDC does not recommend “bulk vaccination for the general public or for all sexually active people” due to a lack of available vaccine. Instead, the government recommends giving vaccines to those who are at a higher risk of serious disease first, such as those who are HIV positive, pregnant, or very young.

McQuiston said that after the FDA’s action, the CDC will soon try to make more people eligible for the shots because there are now more of them.

Officials are still thinking about using the older ACAM2000 vaccine, even though it may have a slightly higher risk of side effects and complications than Jynneos.

“The system currently has millions of ACAM2000 dosages. According to McQuiston, simulations done by the CDC show that it could be used to stop the current outbreak if it is done carefully.

Read More: MONKEYPOX CAUSE AND SYMPTOMS

Related Articles